Literature DB >> 21598006

FTO mRNA expression in extremely obese and type 2 diabetic human omental and subcutaneous adipose tissues.

Belgin Süsleyici-Duman1, Kağan Zengin, Figen Esin Kayhan, Meliha Koldemir, Fatma Kaya Dağıstanlı, Penbe Cağatay, Melek Oztürk, Mustafa Taşkın.   

Abstract

BACKGROUND: Fat mass and obesity-associated protein (FTO) gene expression is known to correlate with obesity. Our aim was to investigate the FTO gene expression in paired omental and subcutaneous human adipose tissues from morbid and obese patients. To understand the role of CD68-positive macrophages in adipose tissues, the correlation with adiposity parameters such as adipocyte diameter and adipocyte radius was also measured. Drug and adiposity correlations were also analyzed.
METHODS: Paired omental and subcutaneous adipose tissue were excised during elective surgery from morbidly obese (n = 9) and obese (n = 5) patients. FTO expressions were determined by quantitative PCR. Tissue sections were analyzed for their CD68 protein expressions by immunuhistochemistry.
RESULTS: Omental and subcutaneous adipose tissue FTO gene expression levels were not found to differ significantly among morbidly obese and obese study groups. Serum aspartate aminotransferase e and alanine transaminase levels were found to be in negative correlation with subcutaneous fat tissue FTO expression rate. Antidiabetic drug use was found to be in correlation with adiposity. Both subcutaneous and omental fat cell diameters were found to have correlation with antidiabetic drug use. Omental fat cell diameter was found to enlarge together with omental CD68 protein expression. Subcutaneous macrophage number decreased while omental fat cell radius increased. Omental macrophage number was found in correlation with subcutaneous macrophage number.
CONCLUSIONS: Antidiabetic therapy was found to increase adiposity in omental and subcutaneous fat. Further research is needed with larger samples to explore the exact role of FTO in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598006     DOI: 10.1007/s11695-011-0446-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  39 in total

1.  Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

Authors:  Gina B Di Gregorio; Aiwei Yao-Borengasser; Neda Rasouli; Vijayalakshmi Varma; Tong Lu; Leslie M Miles; Gouri Ranganathan; Charlotte A Peterson; Robert E McGehee; Philip A Kern
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

2.  Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation.

Authors:  T Peters; K Ausmeier; U Rüther
Journal:  Mamm Genome       Date:  1999-10       Impact factor: 2.957

Review 3.  Metabolic syndrome: a clinical and molecular perspective.

Authors:  David E Moller; Keith D Kaufman
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

Review 4.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots.

Authors:  Anoop Misra; Naval K Vikram
Journal:  Nutrition       Date:  2003-05       Impact factor: 4.008

5.  Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.

Authors:  Lynne E Wagenknecht; Carl D Langefeld; Ann L Scherzinger; Jill M Norris; Steven M Haffner; Mohammed F Saad; Richard N Bergman
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

6.  Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family.

Authors:  C L Holness; R P da Silva; J Fawcett; S Gordon; D L Simmons
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

7.  Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health.

Authors:  Katherine Samaras; Natalia K Botelho; Donald J Chisholm; Reginald V Lord
Journal:  Obes Surg       Date:  2009-09-09       Impact factor: 4.129

8.  Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome.

Authors:  Burcak Vural; Fatmahan Atalar; Cavlan Ciftci; Ayse Demirkan; Belgin Susleyici-Duman; Demet Gunay; Belhhan Akpinar; Ertan Sagbas; Ugur Ozbek; Ahmet Sevim Buyukdevrim
Journal:  Cardiovasc Pathol       Date:  2008-04-15       Impact factor: 2.185

9.  Do stress reactions cause abdominal obesity and comorbidities?

Authors:  P Björntorp
Journal:  Obes Rev       Date:  2001-05       Impact factor: 9.213

10.  The FTO gene is associated with adulthood obesity in the Mexican population.

Authors:  Marisela Villalobos-Comparán; M Teresa Flores-Dorantes; M Teresa Villarreal-Molina; Maricela Rodríguez-Cruz; Ana C García-Ulloa; Lorena Robles; Adriana Huertas-Vázquez; Nubia Saucedo-Villarreal; Mardia López-Alarcón; Fausto Sánchez-Muñoz; Aarón Domínguez-López; Ruth Gutiérrez-Aguilar; Marta Menjivar; Ramón Coral-Vázquez; Gabriel Hernández-Stengele; Victor S Vital-Reyes; Victor Acuña-Alonzo; Sandra Romero-Hidalgo; Doris G Ruiz-Gómez; Daniela Riaño-Barros; Miguel F Herrera; Francisco J Gómez-Pérez; Philippe Froguel; Eduardo García-García; M Teresa Tusié-Luna; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  Obesity (Silver Spring)       Date:  2008-07-31       Impact factor: 5.002

View more
  1 in total

1.  European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2016-05-25       Impact factor: 3.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.